Investors Financial Data

FY 2021 Guidance

• Revenue to grow QoQ by an average of 1.5% to 2.5% in constant currency for Q3 and Q4, FY’21
• EBIT to be between 20.0% and 21.0% for FY’21

Key Highlights (for the quarter ending September 2020)

• HCL signed 15 transformational deals, led by key industry verticals including life sciences and healthcare, public services (energy & utilities) and manufacturing.
• Broad based performance in Q2 with all growth engines firing. All the Geographies / Segments / Verticals return to smart positive sequential growth.
• Strong revenue growth at 4.5% QoQ in constant currency accompanied with expansion in margins on both YoY and QoQ basis.
  EBITDA at 26.6% and EBIT at 21.6% expanded by 320 bps and 160 bps respectively (on YoY basis).
• Mode 2 revenue exceeds US$ 500 mn milestone; EBIT Margin at 18.5% expanding 450 bps (on YoY basis).
• Declared Dividend of INR 4 /- per share, being 71st consecutive quarter of dividend pay-out.
• IT Services attrition (LTM basis) at 12.2%, down 470 bps YoY.
• Cash Generation and conversion continues to be very robust:

  Particulars	Quarter Ended (30-Sep-2020)	Last Twelve Months Ended (30-Sep-2020)
  Operating Cash Flow (US $ mn)	643	2,692
  Free Cash Flow (US $ mn)	578	2,444
  Operating Cash Flow (OCF) / Net Income (NI)	152%	161%
  Free Cash Flow (FCF) / Net Income (NI)	136%	146%

• Gross Cash stands at US $ 2,246 mn and Net Cash at US $ 1,826 mn at the end of September 30th, 2020.
• EPS at INR 45.2 registered healthy growth at 22.0% on LTM basis. Cash EPS INR 60.3 also grew healthy at 36.3% on LTM basis.

To read the investor release, Click Here